Profile for Australia Patent: 2017256774
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2017256774
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Apr 28, 2037 | Novo | OZEMPIC | semaglutide |
| ⤷ Start Trial | Apr 28, 2037 | Novo | WEGOVY | semaglutide |
| ⤷ Start Trial | Apr 28, 2037 | Novo | WEGOVY HD | semaglutide |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
